AskBorsa

October Pharma

OCPH
Fiscal year starts in January · currency EGP · latest: Q2 2026
Next results: Q3 2026 — expected around 23 November 2026estimated from earlier disclosure datesResults calendar ←
179.50EGP+1.81% today1w +5.9%1m −23.8%delayed · 3 November
Net profit · 2024
152million
▼ 16.6% vs 2023
Total assets · 2024
1.41billion
▲ 24.2% vs 2023
Shareholders' equity · 2024
569million
▼ 3.4% vs 2023
Operating cash flow · 2024
43.24million
▼ 71.7% vs 2023

Key facts

Source: annual statements 2024
  • October Pharma's net profit in 2024 was 152 million EGP, down 16.6% from 182 million EGP in 2023.
  • Total assets at the end of 2024 were 1.41 billion EGP, and shareholders' equity 569 million EGP.
  • Operating cash flow in 2024 was positive at 43.24 million EGP.

October Pharma's Q3 2026 results are expected around 23 November — we email you the day they land

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

AI summary

Preparing a summary of the latest results…

Annual net profit last 5 years
Net profit
88.26million
120million
131million
182million
152million
20202021202220232024

Summarised financial statements

Excel · Pro
Swipe the table to see the other years.
Item · EGP20202021202220232024
Income statement
Net profit88.26 million120 million131 million182 million152 million
Gross profit261 million335 million370 million511 million546 million
Total assets606 million553 million950 million1.14 billion1.41 billion
Total liabilities352 million214 million524 million549 million844 million
Shareholders' equity254 million339 million426 million590 million569 million
Total liabilities and equity606 million553 million950 million1.14 billion1.41 billion
Operating cash flow21.39 million262 million-92.33 million153 million43.24 million
Investing cash flow-6.98 million-21.4 million-94.31 million-35.4 million-48.94 million
Financing cash flow-29.28 million-226 million30.41 million-79.09 million12.94 million
Net change in cash-14.86 million14.86 million-9.81 million38.38 million7.23 million
Sign up free to see the full five years for every period.
Sign up free in seconds
With Google or your email, no password.

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. What does this line mean?

Results by period

One page per period: the figures against the same period a year earlier, and the official report.

Financial reports (17)

Other companies in Health Care & Pharmaceuticals

Ranked by latest annual net profit
All companies in the sector ←